NCT05829915 (HomTrainPark) is a NA clinical trial of ROXPro© system (A-Champs) in Parkinson Disease, sponsored by Universidad Rey Juan Carlos.

Who is sponsoring NCT05829915?

NCT05829915 is sponsored by Universidad Rey Juan Carlos.

What drugs are being tested in NCT05829915?

Interventions in NCT05829915: ROXPro© system (A-Champs), No exercise program.

What condition does NCT05829915 study?

NCT05829915 studies Parkinson Disease.

Is NCT05829915 still recruiting?

NCT05829915 is currently completed. Last updated 24 August 2025.

Last reviewed 2025-08-24 · How we verify

NCT05829915: HomTrainPark

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

mHealth Technology in People With Parkinson's Disease

Completed NA Last updated 24 August 2025

What this trial tests

NA trial testing ROXPro© system (A-Champs) in Parkinson Disease in 114 participants. Completed in 30 April 2025.

Timeline

30 March 2023

Primary endpoint
30 January 2024

30 April 2025

Quick facts

Lead sponsor	Universidad Rey Juan Carlos
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	114
Start date	30 March 2023
Primary completion	30 January 2024
Estimated completion	30 April 2025
Sites	1 location across Spain

Drugs / interventions tested

ROXPro© system (A-Champs)
No exercise program

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Universidad Rey Juan Carlos — full company profile →

Who can join

Eligibility, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to explore the feasibility and effectiveness of this type of mHalth technology in the treatment of motor symptoms in people with Parkinson's disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Home-Based time-constrained reactive training enhances movement speed in upper and lower limbs in Parkinson's disease: A randomized controlled trial.
Villamil-Cabello E, Molinero-Martín E, Luque-Casado A, Fernández-Del-Olmo MA. · · 2026 · PMID 41615860 · DOI 10.1177/1877718x251405813

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Universidad Rey Juan Carlos trials

Trials by the same sponsor.

NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
NCT07402902 — Caffeine Strategies and Fat Oxidation · NA · not yet recruiting
NCT07251738 — Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease · not yet recruiting
NCT07247760 — PATIENT SATISFACTION AND MASKING OF WHITE SPOT LESIONS AFTER HOME WHITENING WITH 10% CARBAMIDE PEROXIDE · NA · enrolling by invitation
NCT06968676 — Mixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05829915 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Rey Juan Carlos
Last refreshed: 24 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05829915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing